Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspects
- 1 June 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (6) , 911-916
- https://doi.org/10.1016/0959-8049(94)00433-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cellsBritish Journal of Cancer, 1993
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1993
- Heterogeneity for Allelic Loss in Human Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Feasibility and reproducibility of the [3H]‐thymidine labelling index in breast cancerCell Proliferation, 1991
- Characterization of Laboratory Working Standard for Quality Control of Immunometric and Radiometric Estrogen Receptor Assays. Clinical Evaluation on Breast Cancer BiopsiesTumori Journal, 1989
- Cell kinetics as a prognostic indicator in node-negative breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancerInternational Journal of Cancer, 1989
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- The DNA labelling index: A prognostic factor in node-negative breast cancerBreast Cancer Research and Treatment, 1987
- Tritiated thymidine labelling in Vitro of human cancer of the breast: Counting error and sampling errorEuropean Journal of Cancer and Clinical Oncology, 1986